Tissue polypeptide antigen (TPA) is a protein produced by rapidly growing tissues, such as placenta and neoplasms (Bj6rklund et al., 1976; Bjorklund, 1978) . Increased serum levels of this antigen have been observed in a variety of malignant diseases of different origin: i.e. lung, breast, stomach and colorectal cancer (MenendezBotet et al., 1978; Schlegel et al., 1981) . They have also been detected in several acute and chronic inflammatory conditions, especially liver cirrhosis and acute hepatitis (Bj6rklund, 1980) . Only the occasional report appears in the literature on TPA measurements in pancreatic cancer (Andriulli et al., 1983) . Moreover few data are available on the utility of serum TPA assay in the differential diagnosis between pancreatic cancer and chronic pancreatitis (Panucci et al., 1984) .
The aim of the present investigation was to evaluate the role of TPA in detecting pancreatic malignancy and its value in distinguishing pancreatic cancer from other pancreatic and benign extra-pancreatic gastrointestinal conditions.
A total of 106 subjects were studied: 29 control subjects (19 male, 10 female, age range, 37-66 years) who were healthy members of the medical staff and blood donors; 28 with pancreatic cancer of duct cell origin (Cubilla & Fitzgerald, 1978) (Brown et al., 1981) , chi-square test, Youden index (Armitage, 1971) . Figure 1 illustrates serum levels of TPA. A significantly increased frequency of pathological values was observed in pancreatic cancer patients (x2 = 68.8, P<0.0005). observed between these parameters in pancreatic cancer and chronic pancreatitis.
In the present study TPA increase was almost invariably observed in pancreatic cancer patients (27 out of 28); abnormal values were only occasionally encountered in chronic pancreatitis (2 out of 24). Both normal and increased serum TPA levels were found in extra-pancreatic diseases. These results show that the assay has a good sensitivity for the detection of pancreatic cancer. The sensitivity is similar to that previously reported for Pancreatic oncofoetal antigen (Banwo et al., 1974) and better than that found for other proposed tumour markers (Fabris et al., 1981; Farini et al., 1985; Kalser et al., 1978; Nitti et al., 1982; Reddi & Holland, 1976; Savarino et al., 1984 TPA levels differentiated pancreatic cancer from chronic pancreatitis, and to this extent the specificity of the assay was satisfactory. However, abnormal TPA values were observed in other than neoplastic extra-pancreatic diseases. High levels were frequently found in patients with liver damage; this is supported by the correlations observed between alanine-amino-transferase and albumin on the one hand and TPA on the other. Such correlations were not found in patients with chronic pancreatic disease, suggesting that liver dysfunction does not play an important role in increasing serum TPA levels in pancreatic cancer. These data are in full agreement with our preliminary findings (Panucci et al., 1984) , and confirm the usefulness of TPA in detecting pancreatic malignancy. 
